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Introduction
Lymphatic vessels are indispensable for the maintenance of  plasma and tissue fluid balance, for tissue 
immunosurveillance, and for fat homeostasis (1). Tissue fluid homeostasis is dependent on a delicate 
balance between microvascular filtration (lymph load) and lymphatic resorption (lymph drainage). Dis-
turbances in lymphatic function can contribute to the development of  cardiovascular disease, infection, 
BACKGROUND. Lack of investigatory and diagnostic tools has been a major contributing factor 
to the failure to mechanistically understand lymphedema and other lymphatic disorders in order 
to develop effective drug and surgical therapies. One difficulty has been understanding the true 
changes in lymph vessel pathology from standard 2D tissue sections.
METHODS. VIPAR (volume information-based histopathological analysis by 3D reconstruction 
and data extraction), a light-sheet microscopy–based approach for the analysis of tissue biopsies, 
is based on digital reconstruction and visualization of microscopic image stacks. VIPAR allows 
semiautomated segmentation of the vasculature and subsequent nonbiased extraction of 
characteristic vessel shape and connectivity parameters. We applied VIPAR to analyze biopsies 
from healthy lymphedematous and lymphangiomatous skin.
RESULTS. Digital 3D reconstruction provided a directly visually interpretable, comprehensive 
representation of the lymphatic and blood vessels in the analyzed tissue volumes. The most 
conspicuous features were disrupted lymphatic vessels in lymphedematous skin and a hyperplasia 
(4.36-fold lymphatic vessel volume increase) in the lymphangiomatous skin. Both abnormalities 
were detected by the connectivity analysis based on extracted vessel shape and structure data. 
The quantitative evaluation of extracted data revealed a significant reduction of lymphatic 
segment length (51.3% and 54.2%) and straightness (89.2% and 83.7%) for lymphedematous 
and lymphangiomatous skin, respectively. Blood vessel length was significantly increased in the 
lymphangiomatous sample (239.3%).
CONCLUSION. VIPAR is a volume-based tissue reconstruction data extraction and analysis approach 
that successfully distinguished healthy from lymphedematous and lymphangiomatous skin. Its 
application is not limited to the vascular systems or skin.
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cancer, and obesity. Impaired lymph drainage specifically results in lymphedema (2). It is only very recent-
ly that lymphatic vessels have been considered as an active contributor to these medical conditions (3). A 
dysfunctional lymphatic system may foster the development of  hypertension and atherosclerosis (4, 5), 
and impaired lymphatic function can predispose affected individuals to bacterial and fungal infections (6).
Despite the severe effect of  lymphedema on the quality of  life of  affected individuals, no curative or 
molecularly targeted therapy currently exists (7). Lymphedema appears much more common than general-
ly realized (8, 9). It can be caused by accidental or intended trauma to the lymph-draining pathways, e.g., 
cancer treatment, but there is a hidden lymphedema epidemic, resulting from obesity and poor mobility 
(10). In addition, worldwide infections, such as filariasis, cause millions of  cases, and lymphedema can also 
be caused by genetic defects. Recent advances in identifying causal genes have also provided information 
on the function of  these genes. Indeed genetic factors may be responsible for the development of  many 
secondary forms of  lymphedema, e.g., breast cancer–related lymphedema (11).
A major problem in the clinic is the lack of  investigatory tools to understand the mechanisms of  lymph-
edema. The lack of  techniques for investigation and diagnosis has been a major contributing factor to a 
failure to develop effective drug and surgical therapies. Furthermore, limited investigations have also result-
ed in a failure to discriminate clinically between different phenotypes of  lymphedema, making a specific 
diagnosis more difficult.
The skin histopathology associated with lymphedema has traditionally been analyzed in stained paraf-
fin sections, with a strong emphasis on the prominent aspects hyperkeratosis, fibrotic changes, and inflam-
matory infiltrations. However, lymphatic vessels are difficult to discern in this setting, and, indeed, the 
scarcity of  imaging modalities for assessment of  lymphatic system function and structure has been a sig-
nificant limitation (7). Larger lymph vessel transport can only be imaged through lymphoscintigraphy and 
indocyanine green (ICG) lymphography (12, 13). Lymphoscintigraphy provides functional information on 
lymph transport within a limb but cannot be used to image lymphatic vessels; however, this approach can 
be used to image the accumulation of  tracer within regional lymph nodes within regional lymph nodes. 
ICG lymphography images the contrast within vessels and not the vessel wall in any detail and can image 
lymph drainage routes and contractility of  the vessels in localized areas (14).
Together, lymphoscintigraphy and ICG lymphangiography provide important information on lym-
phatic function and gross architecture of  collecting lymphatic vessels. Fluorescence microlymphangiogra-
phy (FML) and intravital dyes can image initial lymphatics within the skin in vivo (15, 16). Intravital dyes 
are still used to image lymphatic drainage routes to the lymph nodes in order to identify the sentinel node 
prior to biopsy in cancer management. FML is not a standard investigation in the clinical setting. However, 
these valuable clinical imaging modalities do not inform on the pathological details of  the microcircula-
tion, which are particularly relevant for an assessment of  the function of  the initial lymphatics.
Such details at subcellular resolution are revealed in histological sections, which allow, through immu-
nohistochemistry using positively identifying antibodies, the unanimous distinction of  blood and lymphat-
ic vessels. Due to the limited information contained, extraction of  vascular parameters, such as spatial 
structure, connectivity, and network characteristics, is impossible from the standard 2D sections in cellular 
pathology. Theoretically the required volume information could be derived by reconstruction of  the 3D 
vascular architecture from serial sections. However, in practice, this approach is extremely labor intensive, 
and results are often unsatisfactory due to sectioning-associated tissue loss and distortion of  the specimen.
Over the last decade, planar illumination or light-sheet microscopy experienced a brilliant renaissance 
and underwent a rapid technological advancement (17, 18). Light-sheet microscopes generate contiguous 
series of  optical sections from cleared specimen in select cases of  up to a cubic centimeter volume. A full 
representation of  the spatial structure of  the specimen can be generated by digital reconstruction from these 
image stacks. Such light-sheet microscopy methods have been successfully used in experimental 3D recon-
structions and analysis of  developmental processes, the vascular systems, and cancer research (18–22).
We proposed that light-sheet microscopy could be employed to analyze the blood and lymph vessel 
beds in human tissue samples. We asked the question of  whether it was possible to extract characteristic 
and distinguishing parameters that would, with high confidence, identify pathological alterations. In a fea-
sibility study, we have analyzed skin biopsies from healthy volunteers and a patient suffering from primary 
lymphedema associated with WILD (warts, depressed cell-mediated immunity, primary lymphedema, and 
anogenital dysplasia) syndrome (23). To take full advantage of  the power of  light-sheet microscopy, we 
combined imaging of  immunostained, optically cleared skin biopsies at cellular resolution (mesoscopy) 
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with computer-based reconstruction and visualization. For further analysis of  the lymphatic vasculature, 
lymphatic vessel structure was recognized by semiautomatic image analysis (segmentation), and character-
istic parameters were calculated following nonbiased data extraction. This resulted in a volume informa-
tion-based histopathological analysis by 3D reconstruction and data extraction procedure, which we refer 
to using the acronym VIPAR.
Here, we show that, in biopsies from healthy skin, VIPAR distinguished blood and lymphatic vessels 
with high confidence. The digital 3D reconstruction generated a faithful spatial representation of  both ves-
sel beds, which was visually directly accessible and highly informative. Using semiautomated segmentation 
routines, VIPAR extracted the basic shape and connectivity of  the vascular systems, which allowed the 
subsequent nonbiased determination of  fundamental blood and lymph vessel parameters.
Analysis of  patient-derived samples from lymphedematous skin and a lymphangiomatous lesion 
revealed characteristic differences, which were immediately recognizable in the spatial reconstruction. The 
3D visualization uncovered abnormalities, such as the fragmentation of  lymphatic vessels that were not 
immediately identifiable in standard 2D histological sections. Importantly, the visually perceptible structur-
al differences in the lymphatic vessels of  lymphedematous and lymphangiomatous skin were also reflected 
in the extracted vessels parameters. Therefore, VIPAR successfully detected and reported disease-associat-
ed changes in lymphatic vessel structure.
The light-sheet microscopy–based approach we describe here, VIPAR, is not limited to skin samples 
but may be applied to all human tissues that can be optically cleared and where suitable whole-mount 
immunostaining protocols for the target cell population under scrutiny are available. VIPAR provides 
a straightforward practical route to 3D histopathology, which is capable of  bridging the analytical gap 
between microscopic and macroscopic clinical imaging techniques.
Results
Light-sheet microscopy imaging and computer-based visualization provide a faithful representation of  the 3D microvas-
cular anatomy in normal skin. To demonstrate diagnostic potential, we visualized whole-mount immunofluo-
rescence stained human skin biopsies using a LaVision UltraMicroscope II (Supplemental Figure 1, A and 
B; supplemental material available online with this article; https://doi.org/10.1172/jci.insight.93424DS1). 
The resulting image stacks comprising approximately 2,000–4,000 optical sections spaced at 1–2 μm dis-
tance in z were digitally reconstructed using the volume visualization framework Voreen (Supplemental 
Figure 1C) (24, 25).
In our volume reconstructions, the endothelial cell–selective adhesion molecule 1 (ESAM1) (26) served 
as a surrogate marker delineating the position of  blood vessels. Albeit expressed on all endothelial cell 
types, ESAM1 immunoreactivity on lymphatic endothelial cells was comparably weak (Figure 1, A–D). 
Lymphatic vessels were specifically stained by the mucin-type transmembrane surface protein podoplanin 
(PDPN) (27) and nuclear expression of  the transcription factor prospero homeobox protein 1 (PROX1) 
(28), both of  which allowed identification of  lymphatic vessels with high confidence (Figure 1, E–H).
The 3D visualization immediately revealed prominent lymphatic plexuses in the papillary layer (Figure 
1C, red arrow) and at the basis of  the reticular layer (Figure 1C, green arrow) of  the dermis. Both plexuses 
were connected by discontinuously distributed bundles of  blood vessels that often accompanied a lym-
phatic vessel (Figure 1A and Supplemental Video 1). Looking at the papillary plexus en face through the 
epidermis, we immediately identified blind-ending lymphatic capillaries (denoted by asterisks in B, F, and 
H of  Figure 1) and areas composed of  condensed PROX1-expressing lymphatic endothelial cells (denoted 
by opposing white arrows in B, F, and H of  Figure 1). Such condensations (Figure 1, G and H) were fre-
quently observed next to lymph vessel bifurcations, providing additional evidence for our assumption that 
they represent lymphatic valves.
In summary, light-sheet microscopic imaging using the UltraMicroscope II (LaVision) and subsequent 
digital volume reconstruction provided an excellent and immediately interpretable view of  the spatial 
arrangement of  blood and lymph vessels in human skin biopsies. However, the exceptionally high level 
of  complexity provided by volume-based analyses of  vascular parameters complicates the analysis and 
its interpretation. Therefore, we wondered if  it was possible to automatically extract data on the shape 
and spatial structure of  the vascular systems in an unbiased manner that might aid the assessment and 
description of  the vessel systems as well as the identification of  less obvious differences between individual 
samples, thereby allowing deeper phenotyping of  the sample.
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VIPAR, a quantitative approach to histology and histopa-
thology based on 3D reconstruction and volume data extraction. 
Building on the described light-sheet imaging and visualiza-
tion procedure, we developed an analytical workflow, which 
subsequently formed the basis of  the 3D tissue reconstruc-
tion, comprising three additional basic procedures: (a) seg-
mentation, (b) skeletonization, and (c) feature extraction. 
We refer to this entire light-sheet–based imaging, visualiza-
tion, and analysis approach as VIPAR. In an attempt to test 
the power of  VIPAR, we used it for the visualization, 3D 
reconstruction, and quantitative analysis of  the 3D micro-
vascular anatomy in skin biopsies. The deep analysis of  the 
vascular beds by VIPAR, which we report here, is based on 
semiautomated vessel segmentation followed by extraction 
of  characteristic vascular parameters in a completely unbi-
ased manner (Supplemental Figure 1D).
VIPAR rapidly identifies differences between healthy and 
pathological skin samples that require elaborate analysis to be 
revealed by standard histopathology methods. To test the capac-
ity of  VIPAR to distinguish healthy from disease-affected 
tissue and possibly identify pathologies, we analyzed not 
only multiple samples of  healthy skin, but also lymphedema and lymphangiomas skin samples. Diseased 
samples were derived from a 33-year-old Asian male patient with WILD syndrome (Supplemental Figure 
2, A–D) and lymphedema of  the left arm and leg (Supplemental Figure 2, A and B). Lymphatic drainage 
on the left side of  the body was severely diminished, basically resulting in a complete functional lymph 
vessel aplasia (Supplemental Figure 2C). In addition to lymphedema, there was a large papillomatous and 
pedunculated lesion on the left heel, which clinically represented a lymphangiomatous change (Supple-
mental Figure 2, E–G). We therefore compared 3 skin biopsies: (a) normal skin (calf) from three healthy 
volunteers, (b) lymphedema skin (calf), and (c) the lymphangiomatous skin nodule.
We compared the analytic power of  VIPAR with an assessment of  the affected lesions using tradi-
tional 2D histological sections. We therefore immunostained 10-μm cryosections with antibodies directed 
against ESAM1, PDPN, and the lymphatic vessel endothelial hyaluronan receptor 1 (LYVE1) (29). Sec-
tions were either derived from skin of  a healthy leg (Figure 2A) or from lymphedematous skin from the leg 
(Figure 2, B and C). As noted before, ESAM1 was preferentially expressed on blood vessels, while LYVE1 
and PDPN together reliably marked the lymphatic vasculature. Control skin showed the presence of  blood 
Figure 1. Spatial arrangement of blood and lymphatic vessels 
in the human dermis visualized by light-sheet–based micros-
copy. A whole-mount immunostained human skin biopsy from 
a healthy control was analyzed using light-sheet microscopy 
(ultramicroscopy). Shown are projections of 3D computer recon-
structions generated using the volume visualization framework 
Voreen. The depicted antigens are indicated in their respective 
colors on top of the images. ESAM1 served as a general endo-
thelial marker, PROX1 acted as a transcription factor marker, and 
podoplanin (PDPN) identified lymphatic endothelial cells. (A, C, 
E, and G) Visualization of the tissue volume with the papillary 
dermis located at top and the cutaneous plexus at the bottom. (B, 
D, F, and H) Digitally rotated view of the same specimen, showing 
the vessels of the papillary plexus viewed en face through the 
epidermis. (A and C) Papillary and cutaneous lymphatic and blood 
vessel plexuses are distinctly visible (red arrow, papillary plexus; 
green arrow, cutaneous plexus). (B, F, and H) Valves, identified 
by condensed high PROX1 expression (between opposing white 
arrows), were regularly detected in connecting lymphatic (pre-
collector) vessels of the papillary plexus. Blind-ending lymphatic 
capillaries are marked by white asterisks. Scale bars: 100 μm.
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capillaries (2.1% of  total section area) as well as lumenized lym-
phatic vessels (0.4% of  total section area) (Figure 2A). In com-
parison, in the biopsy derived from the lymphedema-affected leg, 
both blood and lymphatic vessel beds appeared dilated, which was 
associated with an increase in the area occupied by blood (3.1% 
of  total section area) and lymphatic (2.4% of  total section area) 
vessels (Figure 2B). In the sections, lymphatic vessels appeared 
without exception lumenized, which is indicative of  fluid uptake 
and does not provide hints toward the underlying pathology. We 
further confirmed this finding in anti-PDPN– and anti-PROX1–
stained sections, which also unambiguously displayed lumenized 
lymphatic vessels (Figure 2C).
As a first step in comparing 2D histology and VIPAR, we probed the light-sheet microscopy–based 
approach by comparing three identically stained skin biopsies from the legs of  three healthy individuals 
(one representative example of  the three is shown in Figure 1 and Figure 2, D, G, and J) with the lymphede-
ma-affected leg sample (Figure 2, E, H, and K) and with the lymphangiomatous sample (Figure 2, F, I, and 
L). In agreement with the histopathological analysis (Figure 2, A–C), the volume reconstruction, which is 
part of  VIPAR, immediately revealed a hyperplasia of  the lymphatic vessels (compare Figure 2, D and G, 
to Figure 2, E and H, and Figure 2, F and I). The lymphatic vessel volume per tissue volume was increased 
from about 1.1% in the control samples to 2.7% in the lymphedema sample and 4.9% in the lymphangio-
matous sample. However, in contrast to standard 2D section–based histology, which had simply identified 
an increase in lumenized lymphatic vessels, VIPAR, in addition, revealed a high number of  hyperplastic 
but also disrupted, isolated lymphatic vessel fragments in the lymphedematous sample (Figure 2E and 
Supplemental Video 2). Such vessel fragments can be expected to be nonfunctional for lymphatic drainage 
and may therefore have contributed to the developing clinical symptoms. Lymph vessels fragmentation 
was specific for the lymphedematous biopsy and not seen in the lymphangiomatous sample with strong 
hyperplasia (Figure 2F and Supplemental Video 3). In both biopsies affected by lymph vessel abnormali-
ties, the clear distinction between the papillary and reticular basal lymphatic plexus was no longer possible. 
In addition, we were struck by the apparent absence of  condensed areas of  PROX1-expressing lymphatic 
endothelial cells, suggesting a lack or deterioration of  lymphatic valves in the precollecting lymphatic ves-
sels (Figure 2, D–F).
Characteristic differences of  lymphatic vessels in healthy and pathologic skin samples were reliably detected by 
VIPAR. 3D reconstruction of  the PDPN-positive lymphatic vasculature revealed immediately recognizable 
differences between healthy skin and both the lymphedematous and lymphangiomatous skin biopsies (Fig-
ure 3, A–C). We now wondered if  these differences were maintained during vessel segmentation and could 
be quantified following the automated data extraction implemented in VIPAR.
For segmentation of  the lymphatic vessels, we applied an interactive semiautomatic random walker 
approach (30) to a downsampled version of  the PDPN-positive channel comprising stacks of  up to 4,000 
Figure 2. Light-sheet microscopy–based analysis of healthy and diseased 
skin biopsies reveals lymph vessel defects that are unrecognizable in 
microtome sections. (A–C) Immunohistological detection of vascular 
markers in microtome sections of healthy control (A) and patient (B and 
C) lower limb skin biopsies. ESAM1, endothelial marker; PDPN, LYVE1, and 
PROX1, lymphatic-specific endothelial markers. Lumenized blood (yellow 
arrows) and lymphatic vessels (white arrowheads) are indicated. Dashed 
line depicts the border between epidermis (indicated by red asterisks) and 
dermis. Scale bars: 100 μm. (D–L) Maximum intensity projections of image 
stacks derived by light-sheet microscopy (UltraMicroscope II) of whole-
mount immunostained control (D, G, and J) and patient skin biopsies (E, F, 
H, I, K, and L). Image stacks were rendered using the volume visualization 
framework Voreen. Detected antigens and respective colors are indicated. 
(D and F) Lymphatic valve areas (identified by high PROX1 expression) are 
marked by white arrows; valve areas were absent in patient biopsies (E 
and F). Specimens are depicted such that the epidermal layer is located on 
the top of the picture (red asterisks). Note acanthosis and hyperkeratosis 
in patient biopsy (B and C). Scale bars: 100 μm.
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optical sections (Figure 3, A–C). Subsequent skeletonization, 
branching point analysis of  the lymphatic morphology, and 
data extraction of  markers potentially distinguishing healthy 
and pathological samples were performed in a nonbiased, ful-
ly automatic fashion. 3D visualization following the segmen-
tation of  lymph vessels indicated that differences in density, 
volume, and organization of  the lymphatic vasculature were 
maintained during the segmentation process. The irregularly 
formed vessel fragments characteristic of  the lymphedematous 
biopsy and the strong hyperplasia of  the lymphangiomatous 
sample were easily visually recognizable in the segmented ves-
sel representation (Figure 3, D–I).
For a quantitative assessment of  changes in the patholog-
ical sample, we used the extracted skeleton (Figure 3, J–L), 
which was based on the binary image generated by segmenta-
tion, to calculate characteristic topological features, including 
the branching points of  lymphatic vessels and their connectiv-
ity (Figure 3, M–O). Besides the branching point distance, the 
length of  the connecting segments, and the segment volume 
(Supplemental Figure 3, A and B), we computed additional morphological features, including average 
radius, roundness (i.e., the ratio between the surface voxels with the largest and smallest distance to the 
medial axis in the cross section), and straightness of  the lymphatic vessel segments (for definitions of  the 
calculated parameters, see Supplemental Figure 3, A–C). A correlation plot depicting Pearson’s correlation 
coefficient for the automatically extracted vascular parameters is shown in Supplemental Figure 4. Segment 
length, distance, and volume showed the highest correlation, suggesting that these parameters describe dif-
ferent aspects of  the same or related structural alterations. In the vessel connectivity analysis, we classified 
each vascular branching point according to the number of  vessel segments connected to this particular node 
(Supplemental Figure 3D). Oblong vessel fragments were classified as a segment delimited by two nodes 
of  branching degree one, as the edges of  these segments were formed by two nodes extending one branch 
each. For sphere-like-shaped small vessel fragments, the two nodes are close together, such that they, due 
to the limited image resolution, degrade to a single node and were consequently classified as a node of  
branching degree zero, since no branches extend from these fragments. Branching points with a connectiv-
ity of  two, which may be generated as an artefact by the current version of  the graph extraction algorithm 
were not considered in this analysis, as they do not represent a true vessel node or branching point in the 
system (Supplemental Figure 3D). For all other vessel segments, the number of  branches extending from 
each edge node was determined as the branching degree (Supplemental Figure 3D). The global branching 
point analysis then classified all nodes in the volume according to their branches (Figure 4G). In addition, 
Figure 3. Automated segmentation of the lymphatic vasculature 
in digital 3D volume reconstructions of control and patient skin 
biopsies. Skin biopsies whole-mount immunostained for PDPN 
were subjected to light-sheet–based microscopy (UltraMicroscope 
II), and the obtained image stacks were visualized using the volume 
visualization framework Voreen (A–C, also shown in Figure 2, 
D–F). Lymphatic vessel surfaces were extracted from the volume 
reconstruction by automatic segmentation of a subvolume using 
a random walker approach, followed by postprocessing. Spatial 3D 
renderings of the specimen are shown from a lateral view where 
the epidermis is located atop the depiction (xz projection, D–F) and 
following a virtual 90° rotation around the x axis, from the en face 
view of the skin, i.e., seen through the epidermis (xy projection, G–I). 
In the control sample, this view largely corresponds to the lymphatic 
vessels of the papillary plexus. Subsequently vessels were skeleton-
ized (J–L), followed by detection and classification of the branching 
points of the vessel convolutes (colored dots in M–O). The rotational 
position of the rendered specimen in space is indicated by the axis 
indicators in the panels.
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for each segment, the higher and lower (per-edge) branching degrees were defined as the maximum/mini-
mum branching degree of  the two nodes connected by the segment. The distribution of  higher branching 
degree for all branches is shown in Figure 4H.
A selection of  parameters that were significantly different between healthy and the two different dis-
eased samples from the patient investigated here are depicted in Figure 4. Segment volume (46.6%, P < 
0.001 and 55.7%, P < 0.001) (Figure 4A), segment length (51.3%, P < 0.001 and 54.2%, P < 0.001) (Figure 
4B), and branching point distance (43.5%, P < 0.001 and 49.1%, P < 0.001) (Figure 4C) were significant-
ly reduced in the lymphedema and lymphangiomatous sample, respectively. Vessel average cross section 
(75.1%, P < 0.001) (Figure 4D) was also reduced in the lymphedematous, but not in the lymphangioma-
tous, sample (102.0%, NS). Average vessel radius was not significantly altered compared with control skin 
(Figure 4E). Straightness (89.2%, P = 0.009 and 83.7%, P < 0.001) (Figure 4F) and roundness (data not 
shown) were again significantly reduced in both,the lymphedematous and lymphangiomatosis sample. In 
addition, the connectivity analysis revealed distinctive differences between healthy and diseased samples. 
Figure 4. Quantitative parameters distinguish the lymphatic vascular network in control and patient skin biopsies following automated extraction of 
vessel shape and connectivity characteristics. Parameters that distinguished the control sample (n = 1) from the lymphedematous (n = 1) and lymphan-
giomatosis sample (n = 1) were calculated from automatically extracted vessel shape and connectivity data. (A–F) The line in the box-and-whisker plots in 
represents the median, the boxes represent the upper and lower quartile, and the end of the whiskers represent the 1.5-fold interquartile range. (G and H) 
Results of the connectivity analysis for (G) total branching point degree and (H) the higher per-edge branching degree. The total branching point analysis 
is cantered on the spheres forming each node, while the higher degree per-edge analysis for each segment considers the maximum branching degree 
of both connected nodes. A total branching point degree of zero therefore represents spherical vascular elements, whereas a higher per-edge branching 
degree of one represents the number of elongated, nonconnected, nonbranched vascular elements. Note the decreased segment length and distance in 
lymphedema- and lymphangiomatosis-affected samples as well as the increased number of spherical and elongated, nonbranched vessel elements in the 
lymphedematous sample. Supplemental Figure 3 provides an overview of the definitions of the extracted parameters depicted in Figure 4. Mann-Whitney 
U test with a Bonferroni correction for multiple comparison was used to compare data between groups. **P < 0.01, ***P < 0.001.
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Compared with the control biopsy, in both samples derived from the patient, the number of  elongated but 
disconnected lymphatic vessel fragments was increased. The lymphedematous sample was, however, more 
strongly affected (Figure 4H). Interestingly, small, isolated spherical vessel fragments were limited to the 
lymphedematous sample (2.38-fold increase) (Figure 4G).
Taken together, in our data sets, distinguishing differences in vessel structure and connectivity were 
maintained during VIPAR-based skeletonization and data extraction. Hence, VIPAR was able to reliably 
reveal distinguishing differences between healthy and two different diseased biopsies. Identification of  
parameters that report robust differences between healthy and lymphedematous samples and, hence, would 
demonstrate the diagnostic power of  VIPAR will require the analysis of  a larger patient collective.
VIPAR is a generally applicable tool for the analysis of  histological samples. Having demonstrated the power 
of  VIPAR for the histopathological analysis of  the dermal lymphatic vasculature, we wanted to extend this 
approach to dermal blood vessels to demonstrate its general applicability. As shown in Figure 1, multicol-
or immunostaining for lymphatic-specific markers (PROX1 and PDPN) and the surrogate blood vascular 
marker (ESAM1) provided a clear distinction of  both vascular systems, enabling the simultaneous analysis 
of  blood and lymphatic vessels in the same specimen.
Assessment of  the blood vasculature was based on ESAM1 immunostaining (Figure 5, A–C). Blood 
vessels were segmented semiautomatically by computing Hessian vesselness features on multiple Gauss-
ian scales (31), followed by manual global thresholding to obtain a binary image and postprocessing to 
remove small segmentation artefacts. The segmented vessel structures were represented as binary volume 
(Figure 5, D–F), and, for subsequent skeletonization, the medial axis within each vessel was computed 
using the voxel-thinning method (Figure 5, G–I) (32). The topology of  the resulting vessel network was 
extracted by identification of  branching points and skeleton voxels that belong to vessel segments based 
on the definitions of  Klette (33). Connectivity analysis and the extraction of  morphological features were 
performed as described for lymphatic vessels.
Despite the high level of  precision achieved during segmentation, we also noted limitations of  the 
applied algorithms, particularly associated with a low signal-to-noise ratio of  the imaging data, resulting in 
segmentation artefacts (Figure 5, B, C, E, F, H, and I, red dashed circles and ellipses). Segmentation errors 
due to high background or low signals led to the addition of  false-positive vessel structures (Figure 5, B, E, 
and H) as well as the loss of  nonsegmented vessels (Figure 5, C, F, and I), respectively.
3D microanatomy of  the dermal blood vasculature and alterations in lymphatic pathologies. 3D reconstruc-
tion of  the healthy dermal blood vessels (Figure 3A) revealed a highly branched, complex-shaped vascu-
lar network. Capillaries of  the papillary plexus (Figure 1C, red arrow) were served and drained by larger 
vessels that traversed the dermis connecting to the reticular basal network (Figure 1C, green arrow). In 
addition, dermal glands were surrounded by a particularly intense blood vascular plexus (Figure 5, A, 
D, and G, red arrow).
Figure 5. Automated segmentation of the blood vasculature 
in digital 3D volume reconstructions of control and diseased 
skin biopsies. (A–C) Digitally generated spatial reconstructions 
of image stacks obtained by light-sheet–based microscopy 
(UltraMicroscope II) of skin biopsies, which were whole-mount 
immunostained for ESAM1. Biopsies were either from the lower leg 
of a healthy control (A, D, and G) or lymphedematous leg skin (B, E, 
and H) or a lymphangiomatous skin biopsy (C, F, and I). Scale bars: 
100 μm. Computer reconstruction and rendering was performed 
using the volume visualization framework Voreen. (D–F) Identified 
by ESAM1 immunostaining, the blood vascular network was seg-
mented in a semiautomated fashion and is represented by digital 
volume rendering. (G–I) Following skeletonization, an automated 
determination of vessel branching points the vascular network was 
performed allowing a classifying node analysis. Note the excep-
tional level of complexity within the healthy control tissue sample 
that was still successfully segmented, skeletonized, and analyzed 
for automated data extraction. Areas of high background signal 
intensity (B, E, and H, red broken circle) can result in false-posi-
tive signals, while a low foreground signal (C, F, and I, red broken 
ellipse) may result in false-negative segmentation results.
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Overall, we analyzed the blood vessels in skin samples from three healthy individuals. Comparable 
staining intensity, patterning, and morphological vascular parameters, including segment length, distance, 
and volume indicated a high degree of  reproducibility of  VIPAR (Figure 6, control 1–3).
In contrast to the mild increase in blood vessel density of  2.1%–3.1% of  the total area measured by 
histopathological analysis in the lymphedematous sample (Figure 2, A and B), 3D reconstruction and anal-
ysis by VIPAR revealed a decrease in blood vessel density as well as a reduced network complexity asso-
ciated with both lymphedema and lymphangiomatosis (Figure 5, B and E, as well as Figure 5, C and F). 
In addition, in the blood vasculature, the structured hierarchic organization of  the papillary and reticular 
plexuses and their connections were absent. Blood vessels in the lymphangiomatous papule appeared to be 
dilated. In contrast to the lymphatic system, branching point distance, segment length, and segment volume 
in lymphedematous and lymphangiomatosis-affected tissue were all significantly increased as compared 
with the controls (Figure 6). This was more pronounced in lymphangiomatosis-affected (2.4-fold distance, 
2.4-fold segment length, 7.4-fold volume) as compared with lymphedematous (1.4-fold distance, 1.4-fold 
segment length, 2.9-fold volume) tissue. The difference between distance and segment length was highly 
significant between lymphedematous and lymphangiomatosis-affected tissue (Figure 6, A and B), while the 
difference in segment volume was less significant (Figure 6C). In addition, the increase in branching point 
distance between controls and the lymphedematous sample was only slight (Figure 6A).
Taken together, VIPAR proved to be suitable for the analysis of  both vascular systems in human skin 
samples. It reliably detected visually obvious defects and allowed a quantitative assessment of  the patho-
logical states lymphedema and lymphangiomatosis following nonbiased data extraction and calculation of  
morphological parameters.
Discussion
In this study, we demonstrate the feasibility of  combining light-sheet microscopy and computer-aided visual-
ization with semiautomated segmentation and nonbiased data extraction to analyze human tissue biopsies.
We performed VIPAR on biopsies of  healthy human skin. VIPAR produced a faithful, digital 
high-resolution 3D representation of  the blood and lymphatic vessel beds, which was directly accessible 
to visual interpretation. The 3D visualization in VIPAR is based on the Voreen visualization framework 
(24, 25), which allows full digital repositioning of  the specimen and, hence, inspection from any viewing 
Figure 6. Determination of distinguishing characteristic 
parameters of the blood vessels in healthy and patient 
samples. Following segmentation and skeletonization, 
the segment properties of the blood vasculature in three 
different control skin biopsies (n = 3), the lymphedematous 
skin biopsy (n = 1), and the lymphangiomatous skin biopsy (n 
= 1) were quantified, according to the definitions provided in 
Supplemental Figure 3. (A) Distance describes the length of 
the direct connection between branching points. (B) Segment 
length corresponds to the length of the center line of a 
vessel between two branching points. (C) The volume of the 
corresponding vessel segment is calculated from the total 
number of voxels associated with the segment. The vessel 
cross section is calculated as the quotient of volume and 
length. Data are presented as box-and-whisker plots, with the 
line depicting the median, the boxes showing upper and lower 
quartile, and the end of the whiskers representing the 1.5-fold 
interquartile range. Note the increased segment length and 
distance in lymphedematous and lymphangiomatous skin 
biopsies. Mann-Whitney U test with a Bonferroni correction 
for multiple comparison was used to compare data between 
groups. *P < 0.05, **P < 0.01, ***P < 0.001.
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angle and at any magnification up to the microscopic resolution limit. Dermal capillary plexuses in the 
biopsy samples plus specific details, such as details of  the initial lymphatics and lymphatic valves, were 
readily recognizable.
Full volume information for both the blood and lymphatic vessel beds allowed semiautomated seg-
mentation and, hence, the extraction of  fundamental shape and connectivity parameters. In a subsequent 
data analysis, characteristic properties, such as the distance between vessel branching points and average 
volume or length of  vessel segments, were calculated. This part of  the analysis was performed in an auto-
mated and therefore nonbiased manner. It was based on all vessel segments present in the entire sample 
volume analyzed.
We applied this procedure to three biopsies of  healthy control skin and observed a high consistency 
of  the derived vascular parameters, demonstrating the robustness of  the technique. This encouraged 
us to probe the capacity of  VIPAR to identify alterations in two diseased skin biopsies obtained from 
a WILD syndrome patient representing lymphedematous and lymphangiomatous skin. Differences in 
vessel structure compared with healthy biopsies were immediately obvious in the lymphedematous sam-
ple. The presence of  isolated, albeit lumenized lymphatic vessel fragments was a distinguishing feature 
that had previously not been identified in this patient before. In histological sections, the missing spatial 
information in the z dimension precluded recognition of  such fragments, which cannot be distinguished 
from contiguous, patent vessels running perpendicular to the sectional plane. The lymphangiomatous 
skin biopsy revealed only little fragmentation but a strong hyperplasia of  the lymphatic vasculature.
The pathological alterations and underlying structural changes that were readily visible in the 3D visu-
alization were also reflected in the subsequent data analysis, as the diseased samples displayed significantly 
changed vascular properties.
The presence of  isolated lymph vessel fragments in the lymphedema skin was reflected in the branching 
analysis, which revealed an increased frequency of  segments with zero branches, i.e., spherical fragments, 
and one branch, i.e., oblong fragments, in the total analysis and, even more strikingly, of  segments with one 
branch per intersection in the higher per-edge branching degree analysis.
We have presently no data on the appearance of  disrupted lymphatic vessels in the patient’s etiology 
of  lymphedema. It would, however, seem plausible that the disruption of  lymphatic vessels may have been 
caused by increasing mechanical strain within edematous tissue. Once present, disrupted lymph vessels 
may have facilitated edema development or aggravated preexisting latent edema. This could have been a 
contributing factor to the delayed manifestation of  the disease in the patient. A robust and quantitative ana-
lytic approach such as VIPAR could aid in defining a threshold for the start of  potential future treatment, 
long before the advent of  clinically manifest symptoms.
The most distinguishing feature of  a sample derived from a lymphangiomatous papule of  the WILD 
patient was the lymph vessel hyperplasia, which was reflected in a 4.36-fold increase of  lymph vessel vol-
ume per tissue volume compared with healthy skin. Remarkably, the segment length (0.47-fold [lymph-
edema], 0.50-fold [lymphangiomatosis] of  control biopsy) and, hence, branching point distance (0.48-fold 
[lymphedema], 0.51-fold [lymphangiomatosis] of  control biopsy) of  lymphatic vessels were significantly 
decreased in both samples with lymphatic abnormalities. Despite the strong lymphatic hyperplasia, i.e., 
vessel distension in the lymphangiomatous sample, the overall result of  the simultaneous shortening of  
vessel fragments was a reduction of  the volume per lymph vessel segment. We interpret the finding that 
concomitantly the vessel straightness was reduced as an indication that the lymphatic vessels have reacted 
to mechanical stretch by extension, very likely through proliferation and increased branching. In contrast, 
segment distance and length were increased for blood vessels, which would argue that the vessel bed was 
distended by the edema and responded less efficiently by vascular remodelling.
The large spectrum of  parameters that can be derived by VIPAR has to be carefully screened for param-
eters that will be significantly altered in the context of  a given pathology. Identification of  such parameters 
would establish VIPAR as a diagnostic tool (Supplemental Figure 4). In our analysis of  the lymphatic 
vessel system, the volume information-based analysis of  skin biopsies compared very favorably with the 
analysis of  histological sections.
Transition from the analysis of  single histological planes to the tissue volume-based VIPAR 
approach is associated with a massive increase in the amount of  evaluated data, which resulted in elimi-
nation of  the variability inevitably introduced by the arbitrary nature of  sectional planes in standard 2D 
histology and enabled the recognition of  phenomena that can be identified far easier and faster in 3D 
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structures. Such pathological, structural alterations were faithfully and quantitatively reflected in the 
extracted descriptive tissue parameters.
Not too surprisingly, the quality of  the achieved vessel segmentation was directly correlated with the 
quality of  the acquired image data. In that respect, we encountered rare false-positive results caused by the 
misinterpretation of  autofluorescent background extracellular matrix components and also the failure to 
detect very dimly stained vessels of  small physical dimensions. Future approaches to minimize these issues 
may entail the development of  improved antibodies and staining protocols, more sensitive microscopic 
image acquisition, and, most importantly, refinement of  the segmentation algorithms. The analysis we 
describe here relies on the availability of  whole-mount immunostaining protocols for the structure or cell 
type under investigation and on subsequent tissue clearing. Recently, a clearing protocol that is compatible 
with a wide variety of  antibodies for immunostaining has been described (34). Alternatively, a variety of  
protocols that retain the fluorescence of  genetically encoded fluorescent proteins have become available 
(35, 36). An obvious cost for the analytical power provided by the VIPAR is the massive amount of  imag-
ing data that need to be handled and evaluated, which presently still require a high-performance graphic 
work station for efficient application. Although decreasing costs for computer memory and data storage 
should rapidly make this approach more affordable, transfer, analysis, and archiving of  large-volume light-
sheet data remains a challenge. For the light-sheet microscopic observation of  developmental processes in 
drosophila and zebrafish, efficient projection algorithms have been designed, resulting in substantial data 
reduction (37). However, in these cases, only the surface of  the developing organisms is of  interest, while, 
for VIPAR, the entire tissue volume must be analyzed, which limits the possible data reduction.
In conclusion, (a) the unique strength of  the VIPAR approach is that it allows a markedly deeper phe-
notyping of  tissue samples than the presently available standard 2D analysis of  sections. We have shown 
here that compared with healthy skin biopsies, skin samples associated with lymphatic vessel disorders 
showed significant differences in their segment length, segment distance, volume per segment, volume of  
lymphatic vessels per tissue volume, and their vessel connectivity, as shown by branching point analysis. (b) 
The VIPAR approach reduces experimental bias through the automated parameter extraction of  VIPAR. 
However, for different pathologies the best outcome parameters will have to be defined. (c) Additional-
ly, the VIPAR approach may provide novel insights into the mechanisms of  disease development and, 
hence, help patient stratification or guide specific treatment once the optimal outcome parameters have 
been defined. In the context of  dermal vascular lymphatic diseases, deep phenotyping using VIPAR will 
provide additional criteria for the diagnostic algorithm for primary lymphatic dysplasia and possibly aid the 
identification of  genetic defects in patients (38).
The VIPAR approach is not limited to the analysis of  vascular structures but can be more widely 
applied to suitable tissue biopsies of  up to 1-cm3 volume. It substantially enhances the detection of  struc-
tural defects and alterations in tissues with a spatially complex arrangement. As it is based on mesoscopic 
light-sheet microscopy, VIPAR also bridges the scales between high-resolution microscopy and whole-body 
imaging. We believe that VIPAR has the potential to open a new field of  3D pathology.
Methods
Light-sheet microscopy. After immunofluorescence whole-mount staining, optically cleared skin biopsies 
were imaged using a LaVision UltraMicroscope II (LaVision BioTec). Stacks were captured with a step size 
of  1 or 2 μm and at different magnifications. 3D reconstruction, analysis, and segmentation and calculation 
of  vascular parameters of  ultramicroscopy stacks were performed using custom software leveraging the 
Voreen framework (24, 25).
Antibodies. The following antibodies were used: rabbit polyclonal anti-human PROX1 (102-PA32, Reli-
aTech), goat polyclonal anti-human PROX1 (AF2727, R&D Systems), goat anti-human LYVE1 (AF2089, 
R&D Systems), mouse anti-human PDPN (clone D2-40, Dako), and mouse anti-human PECAM1 (clone 
89C2, Cell Signaling Technologies). Rabbit antibodies recognizing the extracellular domain of  human 
ESAM1 were raised against an ESAM1-Fc (ESAM-IgG1) fusion protein, produced in stably transfected 
CHO cells. Antigen-specific antibodies of  the serum (VE50) were affinity purified with ESAM1-Fc immo-
bilized on CnBr-Sepharose (GE Healthcare); antibodies against the IgG1 Fc part were removed by incuba-
tion with immobilized human IgG.
Immunofluorescence skin biopsy whole-mount stainings. Fresh skin biopsies were fixed for 4 hours in 4% 
PFA/PBS at 4°C. After permeabilization (0.5% Triton X-100/PBS), the samples were blocked in PermBlock 
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solution (1% BSA, 0.5% Tween 20 in PBS), and whole-mount stainings were performed using anti-PE-
CAM1, anti-ESAM1, anti-PROX1, anti-PDPN, and anti-LYVE1 primary antibodies and Alexa dye–cou-
pled secondary antibodies (Life Technologies) diluted in PermBlock. Following each staining step, samples 
were washed three times in PBS-T (0.1% Tween 20/PBS).
Optical clearing of  skin biopsies. Optical clearing of  tissue samples was described before (39). Briefly, 
whole-mount stained skin biopsies were embedded in 1% low-melting-point agarose. After dehydration in 
methanol (50%, 70%, 95%, >99.0%, >99.0% [v/v] methanol, each step 30 minutes), samples were optically 
cleared in a benzyl alcohol/benzyl benzoate solution (BABB, ratio 1:2 [v/v]) for 4 hours twice. Cleared 
samples were stored in BABB and imaged using a LaVision UltraMicroscope II (39, 40).
Immunohistochemistry. Skin biopsies were fixed for 4 hours in 4% PFA/PBS, washed in PBS, embedded 
and snap-frozen in OCT. 10 μm and 20 μm cryosections were fixed in 4% PFA for 15 minutes, washed and 
blocked (10% chicken serum, 0.3% Triton X-100 in PBS). Subsequently, sections were incubated for 1 hour 
with primary antibodies (diluted in 1% BSA, 1% chicken serum, 0.3% Triton X-100 in PBS), washed three 
times in PBS-T and finally incubated in Alexa dye–conjugated secondary antibodies (Life Technologies). 
After sample mounting in Mowiol (Calbiochem, 475904), confocal images were captured using a Zeiss 
LSM 780 (×20, NA = 0.8 and ×63 oil, NA = 1.4) confocal microscope.
Image processing and analysis. For analysis of  lymphatic and blood vessel properties, we integrated our pro-
cessing pipeline into the volume visualization framework Voreen (Volume Rendering Engine) (24), which 
has been extended to allow the visualization of  large image stacks (25). The analysis workflow consists of  the 
three basic steps: segmentation, skeletonization, and feature extraction. For segmentation of  the lymphatic 
vessels, an interactive semiautomatic random walker segmentation (30) was applied to a downsampled ver-
sion of  the PDPN-positive (D2-40) channel. Segmentation of  blood vessels was performed by computing 
vesselness features on multiple Gaussian scales similar to the method proposed by Sato et al. (31), followed 
by a manual thresholding step to obtain a binary image. Connected component analysis (41) was applied to 
both segmentations in order to identify and remove artifacts in the form of  small voxel components in both 
foreground (spurious objects) and background (cavities). Skeletonization computed the medial axis within 
each vessel, applying the voxel-thinning method proposed by Chen et al. (32). We modified the algorithm in 
order to reduce the number of  spurious branches when iterating on vessels reduced to thin sheets of  voxels. 
Thus we account for anisotropic resolution and nonuniform vessel radius. Topology of  the resulting vessel 
network was extracted by identification of  junctions and skeleton voxels that belonged to vessel segments 
based on a simplified version of  the definitions of  Klette (33). This allows us to identify the connectivity 
of  a voxel solely by observing its 3 × 3 × 3 neighborhood and thus enables computation of  the topology 
of  the complete vessel network in a single sweep over the binary volume. Special voxel configurations that 
necessitate more complicated connectivity computation according to Klette are already ruled out in the post-
processing step of  the segmentation. Segments at the sample boundary were marked and excluded from the 
subsequent analysis of  parameters such as segment length. Based on the binary image obtained by segmenta-
tion in conjunction with the extracted skeleton and the topology of  the vessel network characteristic features 
were calculated. Topological features included the connectivity of  junctions, while morphological features 
of  the vessel segments included average radius, roundness (ratio between the surface voxels with the largest 
and smallest distance to the medial axis in the cross section), and straightness (shortest distance between two 
branching points divided by the segment length).
Lymphoscintigraphy. For visualization of  the whole limb lymph drainage and lymph nodes as well as 
assessment of  lymph transport, a radioactive tracer, Technetium-99m, was injected into the web spaces 
between toes and fingers. Imaging was performed by γ camera, and tracer uptake into the inguinal and 
axillary lymph nodes was quantified 2 hours after injection to determine lymph transport.
Statistics. Per-node and per-edge properties of  each vessel graph are visualized using box-and-whis-
ker plots, with the line depicting the median. The lowest and highest data are those within 1.5 times the 
interquartile range of  the lower and upper quartile. Outliers are displayed individually as small circles. 
Mann-Whitney U test with Bonferroni correction (for multiple comparisons) was used to compare data 
among groups. P < 0.05 was considered statistical significant. All statistical analysis was performed using 
SigmaPlot 11.0.
Study approval. The subject in this study was recruited through the St. George’s Hospital genetic and 
lymphovascular clinic in the United Kingdom. Ethical approval for this study was obtained from the South 
West London Research Ethics Committee, London, United Kingdom (REC ref: 05/Q0803/257). Written 
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informed consent was obtained for the study as well as for photographs of  the patient appearing in the 
manuscript. Ethical approval for the control skin biopsies was obtained from the ethics committee of  the 
medical faculty of  the University of  Münster (ref: 2008-319-f-S). After informed consent was obtained, 
material not required for diagnostic purposes obtained through surgical interventions, independent from 
this study, served as healthy control tissue. All control biopsies were from calf  skin.
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